tiprankstipranks
Advertisement
Advertisement

PMVP Stock Latest News

PMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c)
The FlyPMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c)
10d ago
PMVP
PMV Pharmaceuticals assumed with a Buy at Ladenburg
PremiumThe Fly
PMV Pharmaceuticals assumed with a Buy at Ladenburg
2M ago
PMVP
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters
PremiumCompany Announcements
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters
3M ago
8K
PMVP
PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer
PremiumThe Fly
PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer
4M ago
PMVP
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
PremiumThe Fly
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
4M ago
PMVP
PMVP Earnings this Week: How Will it Perform?
PremiumPre-EarningsPMVP Earnings this Week: How Will it Perform?
4M ago
PMVP
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed
Premium
The Fly
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed
4M ago
KLRA
PMVP
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
Premium
The Fly
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
5M ago
PMVP
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
PremiumCompany Announcements
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
6M ago
PMVP
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
PremiumThe Fly
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
6M ago
PMVP
PMV Pharmaceuticals sees cash runway to end of 2Q27
PremiumThe Fly
PMV Pharmaceuticals sees cash runway to end of 2Q27
6M ago
PMVP
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
6M ago
PMVP
PMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM
PremiumThe FlyPMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM
6M ago
PMVP
PMV Pharmaceuticals Reports Increased Quarterly Loss
Premium
Company Announcements
PMV Pharmaceuticals Reports Increased Quarterly Loss
10M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
Premium
Ratings
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
10M ago
PMVP
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
PremiumRatings
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
10M ago
PMVP
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
PremiumThe Fly
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
10M ago
PMVP
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
PremiumCompany Announcements
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
10M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
PremiumRatings
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
10M ago
PMVP
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
PremiumThe FlyPMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
10M ago
PMVP
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
Premium
Ratings
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
11M ago
PMVP
PMV Pharmaceuticals Reports Promising Phase 2 Trial Results
Premium
Company Announcements
PMV Pharmaceuticals Reports Promising Phase 2 Trial Results
12M ago
8K
PMVP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >